This month, gastroenterologist Jessica Korman, M.D., joins us to discuss one of the more common, yet underscreened, comorbidities that an HIV care provider can encounter in their patient: anal cancer and its precursors.

Korman is a co-author of the newly published ANCHOR study, which explores the value of treating (versus simply observing) high-risk, pre-cancerous anal lesions. In this episode, she shares highlights of the ANCHOR study results, analyzes their clinical implications, and talks about optimal approaches to clinician-patient conversations about anal cancer screening.

Read the full transcript (clicking the link helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-7-anal-cancer-hsil-screening

Our podcast team: Executive producer Myles Helfand; project manager Alina Mogollon-Volk; audio producers/engineers Alex Portaluppi and Lucy Mueller; and podcast editors Maria Elena Perez and Juan Michael Porter II.

Please note that this episode discusses depression and suicide, which some listeners may find triggering. IF YOU NEED HELP: The peer counseling service we discuss within this episode is called the Physician Support Line; it can be reached at 888-409-0141. It is a free service available every day between 8 a.m. and 1 a.m. Eastern Time.     For this podcast, we are stepping away from the discussion around what doctors and medical professionals need to do in order to be better. This framing rarely considers the well-being of medical professionals, or that they themselves often need support and are rarely afforded the grace to ask for it. Many clinicians feel it is potentially damaging to their careers to acknowledge that they are experiencing strain or to ask for help, for fear of facing stigma or being perceived as unable to handle the pressures of their profession.     TheBodyPro contributing editor Juan Michael Porter II speaks with Perry Lin, M.D., FACP, an assistant program director of the internal medicine residency program at Mount Carmel Health System in Columbus, Ohio. The conversation focuses on the expectations medical providers place on themselves; the expectations that society and our systems place on them; the challenges of asking for help; and how systems can change -- and are changing -- to make it easier for clinicians to seek counseling and care when they need it.     Read the full transcript (clicking the link helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-6-mental-health-for-medical-care-providers  

Our podcast team: Executive producer Myles Helfand; audio producers/engineers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; and podcast editors Maria Elena Perez and Juan Michael Porter II.

For this episode, we are looking at the provision of trauma-informed care to people who have experienced sexual assault. This includes, but is not limited to, helping survivors regain a feeling of control, effectively communicating with patients, and offering STI testing. Amanda Reames Pitelli, ANRP, M.S.N., the director of clinical services at Planned Parenthood of Metropolitan Washington, D.C., joins us to talk about simple, specific steps HIV clinicians can take to create a safe space for their patients and improve outcomes.   Our host for this episode, TheBodyPro contributing editor Juan Michael Porter II, uses his own personal experience as a person living with HIV who has been subjected to sexual assault and sub-optimal trauma care as a case study for how to engage with this difficult subject matter.   Read the full transcript (clicking the link helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-5-trauma-informed-care   Our podcast team: Executive producer Myles Helfand; audio producers/engineers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; and podcast editors Maria Elena Perez and Juan Michael Porter II.

There have been quite a few moments from our prior interviews that felt powerful and important, but which didn’t make the cut for the final podcast audio, usually due to time constraints. These are moments that embrace the essence of this podcast, which is to go beyond the data to discuss where HIV medicine and services are changing in the United States, and to talk about how we can learn and adapt to create better outcomes for patients and clients and, ultimately, to lead to a better future.

 

Your co-hosts this month, TheBodyPro executive editor Myles Helfand and contributing editor Juan Michael Porter II, offer analysis as we review never-before-heard conversations with Deborah Cohan, M.D., M.P.H., of the University of California-San Francisco and David Alain Wohl, M.D., of the University of North Carolina. We'll discuss racism, COVID-19, telehealth, and how the answer to so many of the systemic issues we face in HIV care today lies within an approach that focuses on one person at a time, one moment at a time -- and by taking simple steps to acknowledge and respect one another's humanity.

 

Read the full transcript (clicking the link helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-4-human-touch

 

Our podcast team: Executive producer Myles Helfand; audio producers/engineers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; and podcast editors Maria Elena Perez and Juan Michael Porter II.

 

We talk with Chloe Orkin, M.D., about one aspect of our future that in some very concrete ways has already arrived, and yet is currently out of reach for millions: long-acting medical interventions for HIV, the first of which were approved in the U.S. and Europe for treatment over a year ago and approved in the U.S. for prevention late last year. The beginning of the long-acting era has revealed anew some longstanding questions regarding who these drugs primarily benefit, who is able to receive them, and how our entire medical system is set up to serve -- or not serve -- the people who can most benefit from it.   Dr. Orkin is a professor of HIV medicine at Queen Mary University of London and the president of the Medical Women’s Federation. She is one of world’s leading minds in HIV research in medicine -- as well as one of the leading voices in conversations about health equity, access, and anti-discrimination.   Read the full transcript (clicking the link also helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-3-long-acting-antiretrovirals

 

 

Our podcast team: Episode host and executive producer Myles Helfand; audio producers/engineers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; and podcast editors Maria Elena Perez and Juan Michael Porter II.

For our second episode, we tackle structural racism and power differentials in HIV care and services within the U.S. We focus on acknowledging current issues and identifying potential solutions that providers can employ in their daily work. Our staff writer Juan Michael Porter II takes the host chair. 

 

We have two guests in store this month: Michael Chancley, M.S.W., and Deb Cohan, M.D., M.P.H.

 

Chancley is a social worker, educator, writer, and HIV advocate whose work in the South has transformed the lives of thousands. He is the communications manager of PrEP4All and the administrator of PrEP Facts: Rethinking HIV Prevention and Sex, a Facebook group that educates over 20,000 on HIV prevention.

 

Cohan is a professor of obstetrics, gynecology, reproductive services, and family/community medicine at the University of California-San Francisco School of Medicine. She is also the medical director of HIVE, a multidisciplinary clinic based at San Francisco General Hospital that provides reproductive and sexual wellness services to women and couples living with HIV. 

 

Our podcast team: Episode host Juan Michael Porter II; producers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; content editor Maria Elena Perez; and executive editor Myles Helfand.

We review some of the most important clinical developments in HIV that we’ve witnessed in 2021, with an eye toward how those developments will inform and alter our response to HIV in 2022 and beyond.   Our guest: David Alain Wohl, M.D., a professor of medicine in the Division of Infectious Diseases at the University of North Carolina and the site leader of the HIV Prevention and Treatment Clinical Trials Unit at UNC Chapel Hill.   Our topics: HIV and COVID-19; long-acting antiretroviral treatment; PrEP (pre-exposure prophylaxis); and how racism impacts HIV mortality rates.   Our host: Myles Helfand, executive editor of TheBodyPro.   Relevant reading:   -- Top 10 HIV Clinical Developments of 2021: https://www.thebodypro.com/article/hiv-top-10-2021-clinical-developments    -- Cabotegravir PrEP FDA approval: https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention   -- Islatravir trials halted: https://www.aidsmap.com/news/dec-2021/trials-long-acting-islatravir-hiv-treatment-and-prevention-placed-hold   The podcast team: Alex Portaluppi and Lucy Mueller, producers; Alina Mogollon-Volk, project manager; and Maria Elena Perez, content editor.